Ability of T cell subsets and their soluble mediators to modulate the replication of Mycobacterium bovis in bovine macrophages

Pollock, 2002, Mycobacterium bovis infection and tuberculosis in cattle, Vet. J., 163, 115, 10.1053/tvjl.2001.0655 Cosivi, 1998, Zoonotic tuberculosis due to Mycobacterium bovis in developing countries, Emerg. Infect. Dis., 4, 59, 10.3201/eid0401.980108 Buddle, 2001, Vaccination of cattle against Mycobacterium bovis, Tuberculosis, 81, 125, 10.1054/tube.2000.0254 Skinner, 2003, A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis, Infect. Immun., 71, 4901, 10.1128/IAI.71.9.4901-4907.2003 Aldwell, 1996, Bacterial metabolism, cytokine mRNA transcription and viability of bovine alveolar macrophages infected with Mycobacterium bovis BCG or virulent M. bovis, Immunol. Cell Biol., 71, 45, 10.1038/icb.1996.6 Aldwell, 1997, Sequential activation of alveolar macrophages by IFN-gamma and LPS is required for enhanced growth inhibition of virulent Mycobacterium bovis but not M. bovis BCG, Immunol. Cell Biol., 75, 161, 10.1038/icb.1997.22 Werling, 2004, Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists, Immunology, 111, 41, 10.1111/j.1365-2567.2004.01781.x Jungi, 1999, Differential induction of NO synthesis by gram-positive and gram-negative bacteria and their components in bovine monocyte-derived macrophages, Microb. Pathog., 18, 43, 10.1006/mpat.1999.0284 Carpenter, 1998, Antigen-specific lymphocytes enhance nitric oxide production in Mycobacterium bovis BCG-infected bovine macrophages, Immunol. Cell Biol., 76, 363, 10.1046/j.1440-1711.1998.00760.x Zhao, 1997, Effects of gamma interferon and nitric oxide on the interaction of Mycobacterium avium subsp. paratuberculosis with bovine monocytes, Infect. Immun., 651, 761 Liebana, 2002, Cellular interactions in bovine tuberculosis: Release of active mycobacteria from infected macrophages by antigen-stimulated T cells, Immunology, 100, 23 Liebana, 2000, In vitro T-cell activation of monocyte-derived macrophages by soluble messengers or cell-to-cell contact in bovine tuberculosis, Immunology, 100, 194, 10.1046/j.1365-2567.2000.00027.x Skinner, 2002, Cytotoxic T-cell responses to Mycobacterium bovis during experimental infection of cattle with bovine tuberculosis, Immunology, 110, 234, 10.1046/j.1365-2567.2003.01731.x Denis, 1991, Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates, Cell. Immunol., 132, 150, 10.1016/0008-8749(91)90014-3 Nakagawara, 1983, A simple method for counting adherent cells: Application to cultured human monocytes, macrophages and multinucleated giant cells, J. Immunol. Methods, 56, 261, 10.1016/0022-1759(83)90418-0 Evans, 2000, Bioassay for tumor necrosis factors-alpha and -beta, Mol. Biotechnol., 15, 243, 10.1385/MB:15:3:243 Hoft, 2002, Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity, J. Infect. Dis., 186, 1448, 10.1086/344359 Silver, 1998, Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: Requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects, J. Immunol., 160, 2408, 10.4049/jimmunol.160.5.2408 Warwick-Davies, 2001, Enhancement of Mycobacterium tuberculosis-induced tumor necrosis factor alpha production from primary human monocytes by an activated T-cell membrane-mediated mechanism, Infect. Immun., 69, 6580, 10.1128/IAI.69.11.6580-6587.2001 Gutierrez-Pabello, 2002, Upregulation of thymosin beta-10 by Mycobacterium bovis infection of bovine macrophages is associated with apoptosis, Infect. Immun., 70, 2121, 10.1128/IAI.70.4.2121-2127.2002 Flesch, 1994, Growth inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: regulation by endogenous tumor necrosis factor-alpha and by IL-10, Int. Immunol., 6, 693, 10.1093/intimm/6.5.693 Cooper, 1993, Disseminated tuberculosis in interferon gamma gene-disrupted mice, J. Exp. Med., 178, 2243, 10.1084/jem.178.6.2243 Cowley, 2003, CD4+ T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo, J. Immunol., 171, 4689, 10.4049/jimmunol.171.9.4689 Orme, 2001, Immunology and vaccinology of tuberculosis: Can lessons from the mouse be applied to the cow?, Tuberculosis, 81, 109, 10.1054/tube.2000.0257 Walravens, 2002, Analysis of the antigen-specific IFN-gamma producing T-cell subsets in cattle experimentally infected with Mycobacterium bovis, Vet. Immunol. Immunopathol., 84, 29, 10.1016/S0165-2427(01)00398-1 Villarreal-Ramos, 2003, Investigation of the role of CD8+ T cells in bovine tuberculosis in vivo, Infect. Immun., 71, 4297, 10.1128/IAI.71.8.4297-4303.2003 Rhodes, 2001, Antigen recognition and immunomodulation by gamma delta T cells in bovine tuberculosis, J. Immunol., 166, 5604, 10.4049/jimmunol.166.9.5604 Kennedy, 2002, Modulation of immune responses to Mycobacterium bovis in cattle depleted of WC1(+) gamma delta T cells, Infect. Immun., 70, 1488, 10.1128/IAI.70.3.1488-1500.2002 Pollock, 2002, The WC1(+) gammadelta T-cell population in cattle: A possible role in resistance to intracellular infection, Vet. Immunol. Immunopathol., 89, 105, 10.1016/S0165-2427(02)00200-3 Kennedy, 2003, The role of WC1(+) gamma delta T-cells in the delayed-type hypersensitivity (DTH) skin-test reaction of Mycobacterium bovis-infected cattle, Vet. Immunol. Immunopathol., 93, 169, 10.1016/S0165-2427(03)00070-9 Smyth, 2001, In vitro responsiveness of gammadelta T cells from Mycobacterium bovis-infected cattle to mycobacterial antigens: Predominant involvement of WC1(+) cells, Infect. Immun., 69, 89, 10.1128/IAI.69.1.89-96.2001 Vesosky, 2004, Gamma interferon production by bovine gamma delta T cells following stimulation with mycobacterial mycolylarabinogalactan peptidoglycan, Infect. Immun., 72, 4612, 10.1128/IAI.72.8.4612-4618.2004